483
FOAMIX PHARMACEUTICALS, INC.FOAMIX PHARMACEUTICALS, INC. – FDA 483, Apr 24, 2019
Record Details
An FDA inspection of FORMIX PHARMACEUTICALS, INC. in Bridgewater, NJ, revealed significant deficiencies in the conduct and oversight of clinical trials. The firm failed to ensure proper monitoring of studies, leading to undetected serious adverse events and non-compliance with protocol requirements. Additionally, unqualified investigators were selected for a drug study, violating selection criteria.
- Person
View Company Profile
ID · cb497273-e221-4669-b61e-93757721f2c3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.